Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Long-Term Debt Repayments (2016 - 2021)

Xtant Medical Holdings (XTNT) has disclosed Long-Term Debt Repayments for 12 consecutive years, with -$73000.0 as the latest value for Q3 2021.

  • Quarterly Long-Term Debt Repayments fell 282.5% to -$73000.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $411000.0 through Dec 2021, up 30.48% year-over-year, with the annual reading at $411000.0 for FY2021, 30.48% up from the prior year.
  • Long-Term Debt Repayments for Q3 2021 was -$73000.0 at Xtant Medical Holdings, down from $176000.0 in the prior quarter.
  • The five-year high for Long-Term Debt Repayments was $308000.0 in Q1 2021, with the low at -$115000.0 in Q4 2017.
  • Average Long-Term Debt Repayments over 5 years is $85684.2, with a median of $88000.0 recorded in 2018.
  • Peak annual rise in Long-Term Debt Repayments hit 805.88% in 2021, while the deepest fall reached 282.5% in 2021.
  • Over 5 years, Long-Term Debt Repayments stood at -$115000.0 in 2017, then surged by 186.09% to $99000.0 in 2018, then crashed by 39.39% to $60000.0 in 2019, then skyrocketed by 233.33% to $200000.0 in 2020, then tumbled by 136.5% to -$73000.0 in 2021.
  • According to Business Quant data, Long-Term Debt Repayments over the past three periods came in at -$73000.0, $176000.0, and $308000.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.